Liang Zhou
- Hematology top 10%
- Multiple Myeloma Research and Treatments 5
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 5
- Molecular Biology top 10%
- Protein Degradation and Inhibitors 8
- Cell death mechanisms and regulation 7
- Ubiquitin and proteasome pathways 6
- Histone Deacetylase Inhibitors Research 5
- Genomics and Phylogenetic Studies 5
-
- interferon and immune responses 5
- Co-authors
- Steven GrantYun DaiMaciej KmieciakYun LengHui‐Yi LinRobert Z. OrlowskiYu ZhangShuang Chen
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Advanced Materials (1 paper)Angewandte Chemie International Edition (1 paper)
- Partner nations
- ChinaUnited StatesSpain
In The Last Decade
Liang Zhou
78 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 126
- Hematology 147
- Cancer Research 179
- Molecular Biology 737
- Oncology 214
- Immunology 114
Countries citing papers authored by Liang Zhou
This map shows the geographic impact of Liang Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang Zhou more than expected).
Fields of papers citing papers by Liang Zhou
This network shows the impact of papers produced by Liang Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang Zhou. The network helps show where Liang Zhou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Liang Zhou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 8 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 9 | |
| 5 | 2023 | 5 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 4 | |
| 8 | 2022 | 18 | |
| 9 | 2020 | 8 | |
| 10 | 2020 | 19 | |
| 11 | 2020 | 9 | |
| 12 | 2020 | 9 | |
| 13 | 2019 | 22 | |
| 14 | 2018 | 1 | |
| 15 | 2017 | 5 | |
| 16 | 2015 | 8 | |
| 17 | 2015 | 27 | |
| 18 | 2014 | 63 | |
| 19 | 2013 | 46 | |
| 20 | 2010 | 114 |
About Liang Zhou
Liang Zhou is a scholar working on Hematology, Molecular Biology and Cancer Research, having authored 79 papers that have together received 1.2k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (8 papers), Cell death mechanisms and regulation (7 papers), Ubiquitin and proteasome pathways (6 papers), interferon and immune responses (5 papers), Histone Deacetylase Inhibitors Research (5 papers), Multiple Myeloma Research and Treatments (5 papers), Genomics and Phylogenetic Studies (5 papers) and Cancer-related molecular mechanisms research (5 papers). The work is most often cited by research in Hematology (147 citations), Cancer Research (179 citations) and Molecular Biology (737 citations). Liang Zhou has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Steven Grant, Yun Dai, Maciej Kmieciak, Yun Leng, Hui‐Yi Lin, Robert Z. Orlowski, Yu Zhang, Shuang Chen, Richard Jones and Yin Wu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Angewandte Chemie International Edition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.